Google+ Facebook Twitter Twitter

March tech news

Latest tech news for March.

Anaemia reduction

EKF Diagnostics has announced that it is supporting the reduction of anaemia in developing regions of South America.

It is doing so through the use of its point-of-care haemoglobin analysers, as highlighted in a recent international symposium.

EKF’s Hemo Control haemoglobin analyser has been helping the screening and monitoring of anaemia to fight chronic child malnutrition by South American public health programmes for a number of years.  


Antibody discovery

Carterra, the world leader in high-throughput antibody screening and characterisation, has closed a $6m round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners.

The additional funding will support the continued adoption of the innovative Carterra LSA high-throughput Surface Plasmon Resonance (HT-SPR) antibody screening platform and the development of new products and applications.  



In response to the outbreak of coronavirus strain 2019-nCoV, LGC’s SeraCare Life Sciences is developing molecular reference materials for coronavirus, utilising proprietary AccuPlex recombinant technology.  

The control material is being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods directed to 2019-nCoV.

LGC is a manufacturer and leading partner of global in vitro diagnostic manufacturers and clinical laboratories.  

Image credit | iStock



Related Articles

Loss of smell

Through analysing new data collected through an app, Professor Sebastien Ourselin and colleagues have gained new insights into COVID-19 symptoms. 

Neutralising antibodies against SARS-CoV-2

A trio of papers describe newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV.

COVID-19 anti-viral therapy

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

COVID-19: a report from Melbourne, Australia

Medical Scientist Eileen Kelly reports on the impact of COVID-19 in Melbourne and the way the pandemic has been dealt with.